Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WuXi NextCODE Genomics

Division of WuXi PharmaTech Inc.
www.wuxinextcode.com

Latest From WuXi NextCODE Genomics

Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain

Following last December’s partnership in CNS with Autifony, BI undertakes a screening collaboration with Domain. Leo maintains its busy deal-making pace, partnering in dermatology with Evotec.

Deals Business Strategies

China Roundup: Innovent I/O Setback, Adagene, Hua Bag Millions, WuXi Relisting

China biotechs blossom with millions in new funding for antibody developer Adagene and diabetes drug maker Hua Medicine, and a planned CNY5.7bn Shanghai listing for WuXi Apptec. However, national innovation darling Innovent Bio has withdrawn its PD-1 approval filing, dealing a setback to a crowded area.

Financing ImmunoOncology

Asia Executives To Watch: Takeda, Asahi Kasei, Actelion, WuXi NextCode

Takeda appoints a new chief financial official, the third in recent years, and a new consumer health CEO, while WuXi NextCode taps its COO to lead the genomics firm. Senior executives changes also take place at PAREXEL, Asahi Kasei Pharma, and Actelion Japan.

Appointments Asia Pacific

Asia Executives To Watch: Aslan, CanBridge, Sosei, Wuxi NextCode

The New Year brings in new executive moves including a new China GM for ASLAN a new CMO for Sosei, while CanBridge and WuXi NextCode have appointed new VPs.

Appointments Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • NextCODE Health LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • WuXi PharmaTech Inc.
  • Senior Management
  • Rob Brainin, CEO
    John Long, CFO
    Jeff Gulcher, MD, PhD, CSO
    Hakon Guobjartsson, PhD, Chief Informatics Officer
    Jamie Morris, SVP and Commercial General Manager
    Louis Yuan, SVP and China General Manager
    Hongye Sun, PhD, CTO
    John Gu, Chief Digital Officer
    Alex Fowkes, Chief Strategy Officer
  • Contact Info
  • WuXi NextCODE Genomics
    Phone: (617) 218-6159
    55 Cambridge Parkway
    8th Floor
    Cambridge, MA 02142
    USA
UsernamePublicRestriction

Register